Elizabeth H.Z. Thompson

EVP, Head of Research & Dev, Acadia Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$0.5M

Companies

Latest trade

Jul 30, 2026

Companies

Acadia PharmaceuticalsEVP, Head of Research & Dev −$0.5M

Trades

ACAD Sold 16,558 shares at $26.13 · planned $0.4M Jul 30

ACAD Sold 3,435 shares at $21.47 · planned $0.1M Mar 25

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.